Hong Kong · Delayed Price · Currency is HKD Shanghai Henlius Biotech Statistics
Total Valuation
HKG:2696 has a market cap or net worth of HKD 30.37 billion. The enterprise value is 33.83 billion.
| Market Cap | 30.37B |
| Enterprise Value | 33.83B |
Important Dates
The last earnings date was Friday, August 21, 2026.
| Earnings Date | Aug 21, 2026 |
| Ex-Dividend Date | n/a |
Share Statistics
HKG:2696 has 545.26 million shares outstanding. The number of shares has increased by 0.83% in one year.
| Current Share Class | 347.84M |
| Shares Outstanding | 545.26M |
| Shares Change (YoY) | +0.83% |
| Shares Change (QoQ) | -0.13% |
| Owned by Insiders (%) | 0.65% |
| Owned by Institutions (%) | 20.42% |
| Float | 138.96M |
Valuation Ratios
The trailing PE ratio is 30.54 and the forward PE ratio is 29.59.
| PE Ratio | 30.54 |
| Forward PE | 29.59 |
| PS Ratio | 3.54 |
| PB Ratio | 5.80 |
| P/TBV Ratio | n/a |
| P/FCF Ratio | 29.79 |
| P/OCF Ratio | 24.04 |
| PEG Ratio | n/a |
Enterprise Valuation
The stock's EV/EBITDA ratio is 22.51, with an EV/FCF ratio of 33.17.
| EV / Earnings | 33.78 |
| EV / Sales | 3.94 |
| EV / EBITDA | 22.51 |
| EV / EBIT | 32.98 |
| EV / FCF | 33.17 |
Financial Position
The company has a current ratio of 0.78, with a Debt / Equity ratio of 0.87.
| Current Ratio | 0.78 |
| Quick Ratio | 0.57 |
| Debt / Equity | 0.87 |
| Debt / EBITDA | 3.03 |
| Debt / FCF | 4.47 |
| Interest Coverage | 8.88 |
Financial Efficiency
Return on equity (ROE) is 21.83% and return on invested capital (ROIC) is 11.17%.
| Return on Equity (ROE) | 21.83% |
| Return on Assets (ROA) | 4.51% |
| Return on Invested Capital (ROIC) | 11.17% |
| Return on Capital Employed (ROCE) | 10.58% |
| Weighted Average Cost of Capital (WACC) | 6.45% |
| Revenue Per Employee | 2.10M |
| Profits Per Employee | 245,304 |
| Employee Count | 4,082 |
| Asset Turnover | 0.60 |
| Inventory Turnover | 2.60 |
Taxes
In the past 12 months, HKG:2696 has paid 55.94 million in taxes.
| Income Tax | 55.94M |
| Effective Tax Rate | 5.29% |
Stock Price Statistics
The stock price has decreased by -20.42% in the last 52 weeks. The beta is 0.51, so HKG:2696's price volatility has been lower than the market average.
| Beta (5Y) | 0.51 |
| 52-Week Price Change | -20.42% |
| 50-Day Moving Average | 63.27 |
| 200-Day Moving Average | 65.74 |
| Relative Strength Index (RSI) | 44.43 |
| Average Volume (20 Days) | 1,334,588 |
Short Selling Information
| Short Interest | n/a |
| Short Previous Month | n/a |
| Short % of Shares Out | n/a |
| Short % of Float | n/a |
| Short Ratio (days to cover) | n/a |
Income Statement
In the last 12 months, HKG:2696 had revenue of HKD 8.58 billion and earned 1.00 billion in profits. Earnings per share was 1.82.
| Revenue | 8.58B |
| Gross Profit | 6.41B |
| Operating Income | 1.03B |
| Pretax Income | 1.06B |
| Net Income | 1.00B |
| EBITDA | 1.41B |
| EBIT | 1.03B |
| Earnings Per Share (EPS) | 1.82 |
Balance Sheet
The company has 1.10 billion in cash and 4.56 billion in debt, with a net cash position of -3.46 billion or -6.34 per share.
| Cash & Cash Equivalents | 1.10B |
| Total Debt | 4.56B |
| Net Cash | -3.46B |
| Net Cash Per Share | -6.34 |
| Equity (Book Value) | 5.24B |
| Book Value Per Share | 9.61 |
| Working Capital | -1.22B |
Cash Flow
In the last 12 months, operating cash flow was 1.26 billion and capital expenditures -243.55 million, giving a free cash flow of 1.02 billion.
| Operating Cash Flow | 1.26B |
| Capital Expenditures | -243.55M |
| Depreciation & Amortization | 389.01M |
| Net Borrowing | 489.04M |
| Free Cash Flow | 1.02B |
| FCF Per Share | 1.87 |
Margins
Gross margin is 74.69%, with operating and profit margins of 11.95% and 11.67%.
| Gross Margin | 74.69% |
| Operating Margin | 11.95% |
| Pretax Margin | 12.32% |
| Profit Margin | 11.67% |
| EBITDA Margin | 16.42% |
| EBIT Margin | 11.95% |
| FCF Margin | 11.72% |
Dividends & Yields
HKG:2696 does not appear to pay any dividends at this time.
| Dividend Per Share | n/a |
| Dividend Yield | n/a |
| Dividend Growth (YoY) | n/a |
| Years of Dividend Growth | n/a |
| Payout Ratio | n/a |
| FCF Payout Ratio | n/a |
| Buyback Yield | -0.83% |
| Shareholder Yield | -0.83% |
| Earnings Yield | 3.30% |
| FCF Yield | 3.36% |
Fair Value
There are several formulas that can be used to estimate the intrinsic value of a stock.
| Lynch Fair Value | n/a |
| Lynch Upside | n/a |
| Graham Number | |
| Graham Upside |
Analyst Forecast
The average price target for HKG:2696 is 102.15, which is 74.17% higher than the current price. The consensus rating is "Strong Buy".
| Price Target | 102.15 |
| Price Target Difference | 74.17% |
| Analyst Consensus | Strong Buy |
| Analyst Count | 8 |
| Revenue Growth Forecast (3Y) | 9.81% |
| EPS Growth Forecast (3Y) | 11.10% |
Stock Splits
This stock does not have any record of stock splits.
| Last Split Date | n/a |
| Split Type | n/a |
| Split Ratio | n/a |
Scores
HKG:2696 has an Altman Z-Score of 2.84 and a Piotroski F-Score of 6. A Z-score under 3 suggests an increased risk of bankruptcy.
| Altman Z-Score | 2.84 |
| Piotroski F-Score | 6 |